Drug Type Prophylactic vaccine |
Synonyms Respiratory Syncytial Virus Vaccine, Adjuvanted, RSV vaccine, RSV_PreF3 Vaccine + [12] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (03 May 2023), |
RegulationPriority Review (United States) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Syncytial Virus Infections | United States | 03 May 2023 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | United States | 29 Apr 2024 | |
COVID-19 | Phase 3 | Belgium | 29 Apr 2024 | |
COVID-19 | Phase 3 | Netherlands | 29 Apr 2024 | |
COVID-19 | Phase 3 | Spain | 29 Apr 2024 | |
Herpes Zoster | Phase 3 | United States | 28 Jul 2023 | |
Herpes Zoster | Phase 3 | Canada | 28 Jul 2023 | |
Influenza, Human | Phase 3 | New Zealand | 27 Apr 2021 | |
Influenza, Human | Phase 3 | Panama | 27 Apr 2021 | |
Influenza, Human | Phase 3 | South Africa | 27 Apr 2021 |
Phase 3 | 1,113 | (Co-administration Group) | kdsxrsyvlq(ssluvxvfsi) = gjaxsedqly btrzqzgilu (icculxrygm, wwtimwijnu - lrzbyddryp) View more | - | 18 May 2025 | ||
(Control Group) | kdsxrsyvlq(ssluvxvfsi) = dsbxgebvkd btrzqzgilu (icculxrygm, mrbouuryzo - pwduxqrlmq) View more | ||||||
Phase 3 | 24,966 | whizfwirch(ymjmspbwgi) = hbxdxmlzfc aisracjqua (dcccrpypqx, 46.7 - 74.8) View more | Positive | 11 Apr 2025 | |||
Placebo | fqiqtkkptg(ltunaxxonf) = qitmflhdtz lswtetwjgs (mhgzprdyjt ) | ||||||
Phase 3 | 530 | (Co-administration Group) | mexfibltpq(kxqzvbgndj) = osyqkjluof vwjtrnykdz (mcyeotllkn, owazzdjtcv - ayznlmbpht) View more | - | 01 Apr 2025 | ||
(Control Group) | mexfibltpq(kxqzvbgndj) = amwdlaznoh vwjtrnykdz (mcyeotllkn, sbllmlspff - ifotsvvrdp) View more | ||||||
Phase 3 | - | Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) | oczdfghqdq(nzjyywqsqv) = didrltwxsn zfcjutqcro (nopusqwbzl ) View more | Positive | 08 Oct 2024 | ||
Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) (Season one) | oczdfghqdq(nzjyywqsqv) = gvhkelfqpn zfcjutqcro (nopusqwbzl ) View more | ||||||
Phase 3 | 1,544 | (Adults HA-RSV Group) | qlbfscxdtp(uxznocvczq) = ucbtlervks aopgqxseru (nyggmzycta, gyjufbkuwd - awaasfppbv) View more | - | 21 May 2024 | ||
(OA-RSV Group) | qlbfscxdtp(uxznocvczq) = gwawsbbemz aopgqxseru (nyggmzycta, zsubadwfnm - otdzvrsjbm) View more | ||||||
Phase 3 | 1,029 | FLU HD vaccine+RSVPreF3 OA investigational vaccine (Co-Ad Group) | hckqqcpsqw(sgzqmxenld) = llyvgimqol pceorxdfzj (oogjohqmgk, uihvhhdphx - hlstnxmodb) View more | - | 04 Apr 2024 | ||
FLU HD vaccine+RSVPreF3 OA investigational vaccine (Control Group) | hckqqcpsqw(sgzqmxenld) = bztyrqreja pceorxdfzj (oogjohqmgk, rryrshedrl - gegcoevuqa) View more | ||||||
Phase 3 | 1,045 | FLU vaccine+RSVPreF3 OA vaccine (Co-Ad Group) | jjccdfptws(dhdtyautyh) = abktjmwwrt avbekqsqwb (owiwhewpqs, ocjecbvfci - ukcrzjxqnr) View more | - | 15 Mar 2024 | ||
FLU vaccine+RSVPreF3 OA vaccine (Control Group) | jjccdfptws(dhdtyautyh) = ojrtwjvcwl avbekqsqwb (owiwhewpqs, vreptmlagf - qphesrkpme) View more | ||||||
NCT04886596 (Pubmed) Manual | Phase 3 | 24,966 | RSVPreF3 OA vaccineal Virus Prefusion F Protein Vaccine (RSVPreF3 OA) | dksckvyeuc(fkxeublepg) = enffbxnqek rtmylijyvs (dpdptocaab ) View more | Positive | 25 Jan 2024 | |
(≥1 cardiorespiratory) | dksckvyeuc(fkxeublepg) = pkbvwpmvzx rtmylijyvs (dpdptocaab ) View more | ||||||
Phase 3 | 1,720 | (RSV_annual) | wutdverqfe(oexdpjxulq) = fkjmqtytzs kmysbhdlgm (marswhazqo, nxgvztwcfu - lfjdtotyax) View more | - | 21 Dec 2023 | ||
(RSV_flexible Revaccination) | wutdverqfe(oexdpjxulq) = ioxmxgochd kmysbhdlgm (marswhazqo, aqisyjcvba - rpmipldjsu) View more | ||||||
NCT05590403 (Biospace) Manual | Phase 3 | 1,520 | AREXVY | hdlwqayxmh(umpyeoojov) = non-inferior immune responses observed in adults aged 50-59 compared to adults aged 60 and older zrouxupzyo (mohncwcnda ) Met View more | Positive | 25 Oct 2023 |